Nós utilizamos cookies para oferecer a melhor experiência possível aos clientes que visitam nosso website. Se você continuar sem alterar as configurações do seu navegador, nós assumimos que você concorda em receber todos os cookies no website da BioTek. Para conhecer mais sobre como cookies, ou como bloquear cookies, por favor visite nossa política de cookies.

Phenotypic Assays

Assays that quantify disease phenotype changes in cells require no a prior knowledge of disease mechanism of action. A good example of this is in the field of oncology, where uncontrolled cell proliferation is a hallmark of cancer and can be used as the basis for a phenotypic assay. Cytation™ and Lionheart™ can quantify many types of phenotype change, such as counting cells by either fluorescence or brightfield microscopy in the case of cell proliferation. Many other phenotypes can be quantified based on the use of specific fluorescent probes, such as those for oxidative stress, hypoxia, apoptosis, translocation, etc and the image analysis capabilities of Gen5™ Image Prime that provide dual masking capabilities and sub-population analyses based on a wide range of calculated metrics.

 MDA-MB-231-cells-at-20x-0-Hours
MDA-MB-231-cells-at-20x-6-Hours
MDA-MB-231-cells-at-20x-24-Hours

Phase contrast monitoring of MDA-MB-231 cells undergoing oridonin-induced apoptosis at 0, 6 and 20 hrs.

 

Application Notes:

 

Visual Abstracts (.mp4):

BioTek’s Visual Abstracts are brief animated presentations describing the Augmented Microscopy workflow of a specific application.

link